Methods of using microspheres for active embolization
    1.
    发明授权
    Methods of using microspheres for active embolization 有权
    微球用于主动栓塞的方法

    公开(公告)号:US08697137B2

    公开(公告)日:2014-04-15

    申请号:US10220982

    申请日:2001-03-23

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.

    Abstract translation: 本发明涉及包含生物相容的,可溶胀的,基本上亲水的,无毒的和基本上为球形的聚合物材料载体的可注射组合物,其能够有效地输送用于栓塞药物治疗的生物活性治疗因子。 本发明还涉及使用可注射组合物的栓塞基因治疗方法,特别是用于治疗血管生成和非血管生成依赖性疾病的方法。

    Compositions and methods for gene therapy
    2.
    发明申请
    Compositions and methods for gene therapy 审中-公开
    基因治疗的组成和方法

    公开(公告)号:US20060063732A1

    公开(公告)日:2006-03-23

    申请号:US11253435

    申请日:2005-10-18

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) physically linked to a transfection agent for use in embolization gene therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions., using the injectable compositions.

    Abstract translation: 本发明涉及包含生物相容的,可溶胀的,基本上亲水的,无毒的和基本上为球形的聚合物材料载体的可注射组合物,其能够有效地递送与用于栓塞基因治疗的转染剂物理连接的生物活性治疗因子。 本发明还涉及使用可注射组合物的栓塞基因治疗方法,特别是用于使用可注射组合物治疗血管生成和非血管生成依赖性疾病的方法。

    Injectable and swellable microspheres for dermal augmentation
    3.
    发明授权
    Injectable and swellable microspheres for dermal augmentation 有权
    可注射和可溶胀的微球用于皮肤增强

    公开(公告)号:US06790456B2

    公开(公告)日:2004-09-14

    申请号:US10222819

    申请日:2002-08-19

    CPC classification number: A61L27/52 A61L27/26 C08L33/26

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, hydrophilic, non-toxic and substantially spherical microspheres microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further relates to methods of dermal augmentation, particularly for the treatment of skin contour deficiencies, using the injectable compositions.

    Abstract translation: 本发明涉及可注射组合物,其包含生物相容性,可溶胀,亲水,无毒和基本上为球形的微球微球和用于皮肤增生的生物相容性载体。 本发明还涉及使用可注射组合物的皮肤增强方法,特别是用于治疗皮肤轮廓缺陷的方法。

    Injectable and swellable microspheres for dermal augmentation
    6.
    发明授权
    Injectable and swellable microspheres for dermal augmentation 有权
    可注射和可溶胀的微球用于皮肤增强

    公开(公告)号:US06436424B1

    公开(公告)日:2002-08-20

    申请号:US09528990

    申请日:2000-03-20

    CPC classification number: A61L27/52 A61L27/26 C08L33/26

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, hydrophilic, non-toxic and substantially spherical microspheres microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further relates to methods of dermal augmentation, particularly for the treatment of skin contour deficiencies, using the injectable compositions.

    Abstract translation: 本发明涉及可注射组合物,其包含生物相容性,可溶胀,亲水,无毒和基本上为球形的微球微球和用于皮肤增生的生物相容性载体。 本发明还涉及使用可注射组合物的皮肤增强方法,特别是用于治疗皮肤轮廓缺陷的方法。

    Microspheres for active embolization
    10.
    发明授权
    Microspheres for active embolization 有权
    活性栓塞微球

    公开(公告)号:US08741351B2

    公开(公告)日:2014-06-03

    申请号:US13371964

    申请日:2012-02-13

    Abstract: The present invention relates to injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy. The present invention further relates to methods of embolization gene therapy, particularly for the treatment of angiogenic and non-angiogenic-dependent diseases, using the injectable compositions.

    Abstract translation: 本发明涉及包含生物相容的,可溶胀的,基本上亲水的,无毒的和基本上为球形的聚合物材料载体的可注射组合物,其能够有效地输送用于栓塞药物治疗的生物活性治疗因子。 本发明还涉及使用可注射组合物的栓塞基因治疗方法,特别是用于治疗血管生成和非血管生成依赖性疾病的方法。

Patent Agency Ranking